HomeMy WebLinkAboutWORKSHOP Opioid Settlement Fund Workshop PresentationJefferson County
Board of County Commissioners
Opioid Settlement Funds Workshop
Monday, July 7th, 2025
Settlement Funds Distribution:
Washington State Opioid Settlement
within a series of national settlement cases
(One Washington MOU; 50% to state and 50% to local governments)
SBH-ASO: Designated Regional Opioid Abatement Council (OAC)
(10% administrative fee for oversight)
Jefferson County BoCC
(opted for local administration)
Pharmaceutical
Behavioral Health
Advisory Committee
(BHAC - RFP Process)
Distributors
Behavioral Health Consortium (BHC)
Admin: Discovery Behavioral Healthcare
Manufacturers
(undecided)
$0.00
$100,000.00
$200,000.00
$300,000.00
$400,000.00
$500,000.00
$600,000.00
Distributors Pharmaceuticals Manufacturers
Amounts Received to date (as of July 3, 2025)
Amount Received to date (as of July 3, 2025)
Fund Source Amount
Received
Distributors
(BHC)$149,007.56
Pharmaceuticals
(BHAC/RFP)$506,776.68
Manufacturers
(undecided)$35,185.54
Total Received $690,969.78
Distributed (BHC)$149,007.56
Spent (BHC)$119,130.49
Total Distributor
Funds Remaining $29,877.07
Total Funds
Remaining $571,839.29
HOW MUCH SO FAR?
Behavioral
Health
Consortium
Behavioral Health
Advisory Cmte
RFP Process
Undecided
A “Yes” indicates the state participated in the National Settlement for that defendant. A “No” indicates the state has not settled with
that defendant. “Not applicable” indicates the state settled with that defendant outside of the National Settlements.
Source: https://nationalopioidsettlement.com/state-participation-status/
Distributors:
McKesson
AmerisourceBergen
Cardinal Health
Walmart
Johnson & Johnson
Walgreens
Teva
(Purdue Pharma – Not WA?)
Pharmaceuticals:
Janssen Pharmaceuticals
Walmart
Walgreens
Teva
(Purdue Pharma – Not WA?)
(Mallinckrodt – Not WA?)
(Publicis – Not WA?)
Manufacturers:
Johnson & Johnson
Walgreens
Allergan
Teva
(Purdue Pharma – Not WA)
Participants or Consulting Firms (?)
CVS
Kroger
McKinsey & Company
www.opioidsettlementtracker.com/globalsettlementtracker/
#statuses
•Distributor Settlement
to BHC; received
2022 & 2023
payments as of May
2024
•Pharmacy
Settlements to BHAC;
no funds allocated in
2022, funds for 2023
arrived at adjusted
amounts in late 2024;
each settlement is
variable in length;
one-time settlements
are being added as
litigation ensues.
Settlement
Estimates as
of 2022
Payment Year Distributor Janssen Walmart Allergan Teva CVS Walgreens Annual Total
2022 $70,766.72 $0.00
2023 $36,262.38 $71,485.24 $13,265.27 $11,989.61 $14,744.11 $28,716.20 $140,200.43
2024 $45,387.50 $27,013.38 $13,265.27 $11,989.61 $11,754.75 $64,023.01
2025 $45,387.50 $28,043.55 $14,145.35 $11,989.61 $23,490.87 $11,417.98 $89,087.36
2026 $45,387.50 $1,030.17 $15,606.21 $11,989.61 $23,490.87 $11,417.98 $63,534.84
2027 $45,387.50 $1,030.17 $15,606.21 $12,257.83 $26,946.61 $11,417.98 $67,258.80
2028 $60,295.72 $1,030.17 $15,606.21 $14,105.43 $27,636.32 $11,417.98 $69,796.11
2029 $62,801.38 $15,606.21 $14,105.43 $26,255.60 $11,729.39 $67,696.63
2030 $62,801.38 $14,105.43 $24,874.88 $20,350.85 $59,331.16
2031 $52,790.90 $14,105.43 $24,852.97 $20,350.85 $59,309.25
2032 $52,790.90 $14,105.43 $24,852.97 $20,350.85 $59,309.25
2033 $52,790.90 $14,105.43 $20,350.85 $34,456.28
2034 $52,790.90 $14,105.43 $20,350.85 $34,456.28
2035 $52,790.90 $14,105.43 $20,350.85 $34,456.28
2036 $52,790.90 $40,701.69 $40,701.69
2037 $52,790.90 $0.00
2038 $52,790.90 $0.00
Totals:$896,804.78 $129,632.68 $103,100.73 $173,059.71 $228,899.95 $248,924.30 $883,617.37
Apendix A: Opioid Pharmacies Settlements: Estimated Annual Payments as of 2022 - Jefferson County
Estimated Annual Abatement Payments
17 years 13 years10 years13 years7 years6 years
PHARMACEUTICALS
Funds to date:
$506,776.68
MANUFACTURERS
Funds to date:
$35,185.54
DISTRIBUTORS
Funds to date:
$149,007.56
2024:BoCC directed
to Fund 131 for
community RFPs
2025:BHAC to
issue RFPs aligned
with the One WA
MOU
2025: BoCC has not
yet decided how to
allocate
2025 Survey: Most
BHC members
support continuing
collaboration
2024: BoCC directed
to support Beh.
Health Consortium
2025:BoCC
workshop to
discuss options
Behavioral Health Consortium – Membership Survey
Response Summary
One WA MOU Appendix A:
Allowed Uses
Part 1- Treatment
•A. Treat Opioid Use Disorder
•B. Support people in Treatment & Recovery
•C. Connections to Care
•D. Address the needs of Criminal Justice Involved Persons
•E. Address the needs of Pregnant or Parenting Women & Families
Part II – Prevention
•F. Prevent Over Prescribing and Ensure Appropriate Use of Opioids
•G. Prevent Misuse of Opioids
•H. Prevent Overdose Deaths and other Harms
Part III – Other Strategies
•I. First Responders
•J. Leadership, Planning and Coordination
•K. Training
•L. Leadership
•Over 50 people attended, representing many
service sectors across Jefferson County and
people with lived experience.
•Remarks and presentations were provided by the
event’s facilitator, County Commissioner,
Jefferson & Clallam Health Officer, JCPH Director,
Salish BH-ASO Administrator, and JCPH’s
Assessment Team.
•A large-scale exercise and inclusive discussion
occurred, discussing gaps in the behavioral
health network, with emphasis on improving the
support and services for those directly impacted
by Substance Use Disorders.
BHAC
Special
Meeting:
May 30, 2024
Committee members,
community partners,
invited guests, and the
public gathered to
discuss the strategic use
of opioid settlement
funds in Jefferson
County.
•Identified gaps were cross-referenced with the
Abatement Strategies listed in the One WA MOU.
•The group prioritized the following areas of emphasis for
these funds in Jefferson County:
Additional Considerations:
Manufacturer Fund and
Pharmaceutical Fund RFP Process
1. Evaluate Day Center/mobile unit project idea, including and analysis of % impact
on OUD/SUD population.
2. Mental Health Navigator and Jail Medical programs need General Fund support
in 2026 and beyond. (MHN: $30K/yr ; Jail Med: $260K/yr?)
•% OUD/SUD population served? How do we assess and track impact?
3. Existing Drug Court and youth/family support program expansions may be
beneficial to the OUD/SUD population. Assess need and cost.
How do we best encourage data-driven programs
in high-impact areas of service?
Additional Considerations:
Manufacturer Fund and
Pharmaceutical Fund RFP Process
4. All of these programs can apply for RFP – should we add Manufacturer $ to that larger “pot”?
5. Or during budget process, should we consider direct appropriations to existing programs as long as
they can demonstrate direct benefit to OUD/SUD affected population, per the One WA MOU
guidance? Or continue to consider them along with other programs per the RFP process?
6. Jefferson County is in the Olympic Community of Health Region (Clallam, Jefferson, and Kitsap
Counties) – could OCH assist with any collaborative approaches?Are there OUD/SUD experts to
consult to maximize effectiveness of programs (i.e., Nat’t Overdose Prevention Network)?
7. All the funds are unpredictable: varying lengths and amounts – cannot be considered reliable as an
ongoing funding source.
How do we best encourage data-driven programs
in high-impact areas of service?
Recommendations and Next Steps
1.
4.
2.
3.
Decide Manufacturer
fund use by March 23,
2026—OR integrate into
RFP process
Evaluate 4 programs/projects for
measurable impact to IMPROVE THE
LIVES OF PEOPLE SUFFERING FROM
OUD/SUD and their families:
1. Mental Health Navigator (existing)
2. Jail Medical program (existing)
3. Drug Court program (existing + growth)
4. Urban Rest Stop/Day Center (future)
Transfer Pharmaceutical
funds to Fund 131 and
request Treasurer
investment
BHC to recommend any
changes to Distributor fund
allocation by Nov 3, 2025